1-1 of 1
Yuanxiang Lin
Close
Sort by
Journal Articles

A Phase II Study of the Efficacy and Safety of the Srmt (Sintilimab, Rituximab, Methotrexate, and Temozolomide) Regimen in Newly Diagnosed Primary Central Nervous System Lymphoma

Zhiyong Zeng, Apeng Yang, Yuanxiang Lin, Junmin Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 857.
https://doi.org/10.1182/blood-2023-180978
Published: 2023